Skip to content
Recall Observatory FDA recall evidence

Drug product

Fentanyl Transdermal System. 75 mcg/h, packaged in 5 pouch system (NDC 0591-3213-72), Rx Only, Manufactured by: Actavis Laboratoies UT, Inc. Salt Lake City, UT 84108, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA. Individual pouch NDC 0591-3213-54.

D-0542-2018

January 29, 2018

Class III

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 79062
Status
Terminated
Classification
Class III
Quantity
576, 760 (5 pouches/carton)
Official record key
drug-enforcement:D-0542-2018

Official wording

Reason: Failed Impurities/Degradation Specifications: Fentanyl-n-Oxide (FNO) degradant exceeding the specification limits

Code information: Lot #: 1107745A, Exp. Mar 2018;1122452A, 1137109A, Exp. Jun 2018; 1144515A, Exp. Oct 2018; 1189477A, Exp. Mar 2019; 1215224A, Exp. Aug 2019.

Distribution pattern: Distributed nationwide within the United States

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications